CORONARY HEART DISEASE TOGETHER WITH DIABETES POSES A SERIOUS HEALTH THREAT

Afzal Qasim, Muhammad Inam Qureshi, Darshan kumar, Muhammad Umar Khan

Abstract


Among various risk factors, the most important is diabetes and its prime form, type 2 diabetes mellitus
(T2DM), and has idiosyncratic connection with coronary heart disease (CHD). Diabetes patients have two- to
four-fold higher threat of developing coronary disease than the people without diabetes, and cardio-vascular
disease (CVD) is responsible for an irresistible 65-75 per cent of deaths in people with diabetes. Moreover considerably
the age and sex-adjusted mortality risk in diabetic patients without pre-existing coronary artery disease
was found to be equal to that of non-diabetic individuals with prior myocardial infarction (MI). These incredible
results concerning higher risk of mortality have led to doubt that widespread precursors predispose to diabetes
and CHD with subsequent implications that insulin resistance, visceral adiposity, and excess inflammation cause
the pathophysiology of thrombogenesis. In addition, a complex mix of mechanistic processes such as oxidative
stress, enhanced atherogenecity of cholesterol particles, abnormal vascular reactivity, augmented haemostatic
activation, and renal dysfunction have been proposed as features characteristic of T2DM that may confer excess
risk of coronary heart disease.

Keywords


Idiosyncratic; Pathophysiology; Thrombogenesis; Atherogenecity Visceral Adiposity

Full Text:

PDF

References


World Health Organization. World Health Statistics. Department of Measurement and Health Information Systems of the Information, Evidence and Research Cluster. Geneva: WHO Press; 2008. p. 29-31.

Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125: 217-30.

McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993; 87: 152-61.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 2: 1047-53.

Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007; 297: 286-94.

Ramachandran A, Snehalatha C, Latha E, Satyavani K, Vijay V. Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care 1998; 21: 967-71.

Diaz VA, Mainous AG, Baker R, Carnemolla M, Majeed A. How does ethnicity affect the association between obesity and diabetes? Diabet Med 2007; 24: 1199-204.

Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ 2004; 328: 807-10.

Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001; 25: 1722-5.

Gupta R, Gupta VP, Sarna M, Prakash H, Rastogi S, Gupta KD. Serial epidemiological surveys in an urban Indian population demonstrate increasing coronary risk factors among the lower socioeconomic strata. J Assoc Physicians India 2003; 51: 470-77.

Vijan S, Stevens DL, Herman WH, Funnell MM, Standiford CJ. Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus putting evidence into practice. J Gen Int Med 1997; 12: 567-80.

Wang TJ, Ausiello JC, Stafford RS. Trends in antihypertensive drugs advertising 1985-1996. Circulation 1999; 99: 2055-57.

Avorn J. Torcetrapib and atorvastatin – should marketing drive the research agenda? N Engl J Med 2005; 352: 2573-6.

Kris-Etherton P, Eckel RH, Howard BV, St. Jeor S, Bazzarre TL. Lyon Diet Heart Study: Benefits of a Mediterranean-Style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 2001; 103: 1823-5.

Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review. JAMA 2003; 290: 86-97.

Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT. 10-years follow-up of diabetes incidences and weight loss in the diabetes prevention program outcomes studies. Lancet 2009; 374: 1677-86.

Mozaffarian D, Wilson PWF, Kannel WB. Beyond established and novel risk factors: Lifestyle risk factors for cardiovascular disease. Circulation 2008; 17: 3031-8.

Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall study. Br Med J 1983; 28: 867-70.

Dilley J, Ganesan A, Deepa R, Deepa M, Sharada G, Williams OD. Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance. Diabetes Care 2007; 30: 1527-32.

Srikanth S, Deedwania P. Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach. Cardiol Clin 2005; 23: 193-210.

Haffner SJ, Cassells H. Hyperglycemia as a cardiovascular risk factor. Am J Med 2003; 115 (Suppl 8A): 6S-11S.

United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin, compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-53.

Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007; 167: 1145-51.

Laakso M, Kuusisto J. Epidemiological evidence for the association of hyperglycemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 1996; 28: 415-8.

Haffner SM. Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol 1999; 84: 11J-14J.

Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005; 118: 939-47.

Kannel WB, McGee DL. Diabetes and cardiovascular disease, The Framingham study. JAMA 1979; 24: 2035-8.

Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 1999; 281: 1291-7.

Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Afzal Qasim, Muhammad Inam Qureshi, Darshan kumar, Muhammad Umar Khan

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.